AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Sanofi Director's Dealing 2012

Oct 9, 2012

1643_dirs_2012-10-09_1643afb3-f654-4071-9478-0915a6d02b02.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Regulus Therapeutics Inc. (RGLS)
CIK: 0001505512
Period of Report: 2012-10-04

Reporting Person: Sanofi (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3749999	Indirect

Footnotes

F1: By wholly-owned subsidiary